TNF and inflammatory bowel disease: Biological therapies currently used in the treatment of IBD include three main classes of monoclonal antibodies: anti-TNF-α, anti-integrins (α4β7 integrin-receptor antagonist), and anti-interleukin (IL) 12/23.